{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T19:41:30Z","timestamp":1790710890720,"version":"4.1.0"},"reference-count":218,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T00:00:00Z","timestamp":1628553600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100015080","name":"Fundaci\u00f3n Rafael del Pino","doi-asserted-by":"publisher","award":["C\u00e1tedra Rafael del Pino en Oftalmolog\u00eda"],"award-info":[{"award-number":["C\u00e1tedra Rafael del Pino en Oftalmolog\u00eda"]}],"id":[{"id":"10.13039\/501100015080","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011941","name":"Gobierno del Principado de Asturias","doi-asserted-by":"publisher","award":["IDE\/2019\/000289"],"award-info":[{"award-number":["IDE\/2019\/000289"]}],"id":[{"id":"10.13039\/100011941","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biology"],"abstract":"<jats:p>Glaucoma is an insidious group of eye diseases causing degeneration of the optic nerve, progressive loss of vision, and irreversible blindness. The number of people affected by glaucoma is estimated at 80 million in 2021, with 3.5% prevalence in people aged 40\u201380. The main biomarker and risk factor for the onset and progression of glaucoma is the elevation of intraocular pressure. However, when glaucoma is diagnosed, the level of retinal ganglion cell death usually amounts to 30\u201340%; hence, the urgent need for its early diagnosis. Molecular biomarkers of glaucoma, from proteins to metabolites, may be helpful as indicators of pathogenic processes observed during the disease\u2019s onset. The discovery of human glaucoma biomarkers is hampered by major limitations, including whether medications are influencing the expression of molecules in bodily fluids, or whether tests to validate glaucoma biomarker candidates should include human subjects with different types and stages of the disease, as well as patients with other ocular and neurodegenerative diseases. Moreover, the proper selection of the biofluid or tissue, as well as the analytical platform, should be mandatory. In this review, we have summarized current knowledge concerning proteomics- and metabolomics-based glaucoma biomarkers, with specificity to human eye tissue and fluid, as well the analytical approach and the main results obtained. The complex data published to date, which include at least 458 different molecules altered in human glaucoma, merit a new, integrative approach allowing for future diagnostic tests based on the absolute quantification of local and\/or systemic biomarkers of glaucoma.<\/jats:p>","DOI":"10.3390\/biology10080763","type":"journal-article","created":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T22:40:31Z","timestamp":1628635231000},"page":"763","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Candidate Glaucoma Biomarkers: From Proteins to Metabolites, and the Pitfalls to Clinical Applications"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7320-3368","authenticated-orcid":false,"given":"Andr\u00e9s","family":"Fern\u00e1ndez-Vega Cueto","sequence":"first","affiliation":[{"name":"Instituto Oftalmol\u00f3gico Fern\u00e1ndez-Vega, Avda. Dres. Fern\u00e1ndez-Vega, 34, 33012 Oviedo, Spain"},{"name":"Instituto Universitario Fern\u00e1ndez-Vega, Fundaci\u00f3n de Investigaci\u00f3n Oftalmol\u00f3gica, Universidad de Oviedo, 33012 Oviedo, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0604-7411","authenticated-orcid":false,"given":"Lydia","family":"\u00c1lvarez","sequence":"additional","affiliation":[{"name":"Instituto Universitario Fern\u00e1ndez-Vega, Fundaci\u00f3n de Investigaci\u00f3n Oftalmol\u00f3gica, Universidad de Oviedo, 33012 Oviedo, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9983-546X","authenticated-orcid":false,"given":"Montserrat","family":"Garc\u00eda","sequence":"additional","affiliation":[{"name":"Instituto Oftalmol\u00f3gico Fern\u00e1ndez-Vega, Avda. Dres. Fern\u00e1ndez-Vega, 34, 33012 Oviedo, Spain"},{"name":"Instituto Universitario Fern\u00e1ndez-Vega, Fundaci\u00f3n de Investigaci\u00f3n Oftalmol\u00f3gica, Universidad de Oviedo, 33012 Oviedo, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8765-8352","authenticated-orcid":false,"given":"Ana","family":"\u00c1lvarez-Barrios","sequence":"additional","affiliation":[{"name":"Instituto Universitario Fern\u00e1ndez-Vega, Fundaci\u00f3n de Investigaci\u00f3n Oftalmol\u00f3gica, Universidad de Oviedo, 33012 Oviedo, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enol","family":"Artime","sequence":"additional","affiliation":[{"name":"Instituto Universitario Fern\u00e1ndez-Vega, Fundaci\u00f3n de Investigaci\u00f3n Oftalmol\u00f3gica, Universidad de Oviedo, 33012 Oviedo, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Fern\u00e1ndez-Vega Cueto","sequence":"additional","affiliation":[{"name":"Instituto Oftalmol\u00f3gico Fern\u00e1ndez-Vega, Avda. Dres. Fern\u00e1ndez-Vega, 34, 33012 Oviedo, Spain"},{"name":"Instituto Universitario Fern\u00e1ndez-Vega, Fundaci\u00f3n de Investigaci\u00f3n Oftalmol\u00f3gica, Universidad de Oviedo, 33012 Oviedo, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Coca-Prados","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Science, Yale University School of Medicine, New Haven, CT 06510, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5251-0967","authenticated-orcid":false,"given":"H\u00e9ctor","family":"Gonz\u00e1lez-Iglesias","sequence":"additional","affiliation":[{"name":"Instituto Oftalmol\u00f3gico Fern\u00e1ndez-Vega, Avda. Dres. Fern\u00e1ndez-Vega, 34, 33012 Oviedo, Spain"},{"name":"Instituto Universitario Fern\u00e1ndez-Vega, Fundaci\u00f3n de Investigaci\u00f3n Oftalmol\u00f3gica, Universidad de Oviedo, 33012 Oviedo, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,8,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1016\/S0140-6736(17)31469-1","article-title":"Glaucoma","volume":"390","author":"Jonas","year":"2017","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1136\/bjo.2005.081224","article-title":"The number of people with glaucoma worldwide in 2010 and 2020","volume":"90","author":"Quigley","year":"2006","journal-title":"Br. J. Ophthalmol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1016\/j.ophtha.2014.05.013","article-title":"Global prevalence of glaucoma and projections of glaucoma burden through 2040: A systematic review and meta-analysis","volume":"121","author":"Tham","year":"2014","journal-title":"Ophthalmology"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1001\/jama.2014.3192","article-title":"The pathophysiology and treatment of glaucoma: A review","volume":"311","author":"Weinreb","year":"2014","journal-title":"JAMA J. Am. Med. Assoc."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.preteyeres.2004.10.003","article-title":"Changes in aqueous humor dynamics with age and glaucoma","volume":"24","author":"Gabelt","year":"2005","journal-title":"Prog. Retin. Eye Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1442-9071.2012.02773.x","article-title":"Definition of glaucoma: Clinical and experimental concepts","volume":"40","author":"Casson","year":"2012","journal-title":"Clin. Exp. Ophthalmol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"4170","DOI":"10.1167\/iovs.05-0289","article-title":"Pathophysiologic changes in the optic nerves of eyes with primary open angle and pseudoexfoliation glaucoma","volume":"46","author":"Gottanka","year":"2005","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S1350-9462(99)00019-1","article-title":"Exfoliation syndrome and exfoliation glaucoma","volume":"19","author":"Vesti","year":"2000","journal-title":"Prog. Retin. Eye Res."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ejpb.2015.04.029","article-title":"The aqueous humor outflow pathways in glaucoma: A unifying concept of disease mechanisms and causative treatment","volume":"95","author":"Braunger","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Schl\u00f6tzer-Schrehardt, U., and Naumann, G.O.H. (2006). Ocular and Systemic Pseudoexfoliation Syndrome. Am. J. Ophthalmol., 141.","DOI":"10.1016\/j.ajo.2006.01.047"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"S83","DOI":"10.1097\/IJG.0000000000000906","article-title":"Mechanisms of Glaucoma in Exfoliation Syndrome","volume":"27","author":"Ozaki","year":"2018","journal-title":"J. Glaucoma"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1038\/s41433-018-0042-2","article-title":"Normal tension glaucoma: Review of current understanding and mechanisms of the pathogenesis \/692\/699\/3161\/3169\/3170 \/692\/699\/3161 review-article","volume":"32","author":"Killer","year":"2018","journal-title":"Eye"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1097\/00006324-199908000-00022","article-title":"Glaucoma screening: The importance of combining test data","volume":"76","author":"Harper","year":"1999","journal-title":"Optom. Vis. Sci."},{"key":"ref_14","first-page":"741","article-title":"Number of ganglion cells in glaucoma eyes compared with threshold visual field tests in the same persons","volume":"41","author":"Quigley","year":"2000","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s40135-019-00213-0","article-title":"Molecular Biomarkers for Glaucoma","volume":"7","author":"Beykin","year":"2019","journal-title":"Curr. Ophthalmol. Rep."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1067\/mcp.2001.113989","article-title":"Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework","volume":"69","author":"Atkinson","year":"2001","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1177\/009286150704100504","article-title":"Molecular biomarkers","volume":"41","author":"Laterza","year":"2007","journal-title":"Drug Inf. J."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1167\/iovs.12-11067","article-title":"Molecular biomarkers in glaucoma","volume":"54","author":"Bhattacharya","year":"2013","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1080\/13543776.2019.1667336","article-title":"Diagnostic markers for glaucoma: A patent and literature review (2013-2019)","volume":"29","author":"Bua","year":"2019","journal-title":"Expert Opin. Ther. Pat."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.survophthal.2007.08.011","article-title":"What Are the Biomarkers for Glaucoma?","volume":"52","author":"Golubnitschaja","year":"2007","journal-title":"Surv. Ophthalmol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"100875","DOI":"10.1016\/j.preteyeres.2020.100875","article-title":"Discovery and clinical translation of novel glaucoma biomarkers","volume":"80","author":"Beykin","year":"2021","journal-title":"Prog. Retin. Eye Res."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Agnifili, L., Pieragostino, D., Mastropasqua, A., Fasanella, V., Brescia, L., Tosi, G.M., Sacchetta, P., and Mastropasqua, L. (2015). Molecular Biomarkers in Primary Open-Angle Glaucoma: From Noninvasive to Invasive, Elsevier B.V.. [1st ed.].","DOI":"10.1016\/bs.pbr.2015.05.006"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1586\/eop.10.73","article-title":"Biomarkers of primary open-angle glaucoma","volume":"5","author":"Knepper","year":"2010","journal-title":"Expert Rev. Ophthalmol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1515\/cclm-2012-0048","article-title":"Biomarkers in primary open angle glaucoma","volume":"50","author":"Kokotas","year":"2012","journal-title":"Clin. Chem. Lab. Med."},{"key":"ref_25","first-page":"1","article-title":"Clinical metabolomics and glaucoma","volume":"59","author":"Himmelreich","year":"2017","journal-title":"Ophthalmic Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1080\/14789450.2017.1298448","article-title":"The potential impact of recent insights into proteomic changes associated with glaucoma","volume":"14","author":"Funke","year":"2017","journal-title":"Expert Rev. Proteom."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"103881","DOI":"10.1016\/j.jprot.2020.103881","article-title":"Review of proteomics approach to eye diseases affecting the anterior segment","volume":"225","author":"Aghamollaei","year":"2020","journal-title":"J. Proteom."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1097\/IJG.0000000000000117","article-title":"Metabolomics\/proteomics strategies used to identify biomarkers for exfoliation glaucoma","volume":"23","author":"McNally","year":"2014","journal-title":"J. Glaucoma"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/prca.201300115","article-title":"A decade of proteomics studies of glaucomatous neurodegeneration","volume":"8","author":"Tezel","year":"2014","journal-title":"Proteom. Clin. Appl."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.preteyeres.2013.01.004","article-title":"A proteomics view of the molecular mechanisms and biomarkers of glaucomatous neurodegeneration","volume":"35","author":"Tezel","year":"2013","journal-title":"Prog. Retin. Eye Res."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.coph.2012.09.005","article-title":"Autoimmune biomarkers in glaucoma patients","volume":"13","author":"Gramlich","year":"2013","journal-title":"Curr. Opin. Pharmacol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.preteyeres.2013.02.003","article-title":"Does autoimmunity play a part in the pathogenesis of glaucoma?","volume":"36","author":"Bell","year":"2013","journal-title":"Prog. Retin. Eye Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s13167-010-0031-4","article-title":"Key molecular pathways affected by glaucoma pathology: Is predictive diagnosis possible?","volume":"1","author":"Golubnitschaja","year":"2010","journal-title":"EPMA J."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1080\/15321819.2020.1726774","article-title":"Biomarkers of inflammation and oxidative stress in ophthalmic disorders","volume":"41","author":"Ahmad","year":"2020","journal-title":"J. Immunoass. Immunochem."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/bs.pbr.2015.06.001","article-title":"Oxidative stress and mitochondrial failure in the pathogenesis of glaucoma neurodegeneration","volume":"220","year":"2015","journal-title":"Prog. Brain Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.freeradbiomed.2008.04.026","article-title":"Oxidative and nitrative stress markers in glaucoma","volume":"45","author":"Aslan","year":"2008","journal-title":"Free Radic. Biol. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.coph.2012.10.007","article-title":"Evaluation of presumptive biomarkers of oxidative stress, immune response and apoptosis in primary open-angle glaucoma","volume":"13","year":"2013","journal-title":"Curr. Opin. Pharmacol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1167\/iovs.12-9781","article-title":"The pathogenesis of glaucoma in the interplay with the immune system","volume":"54","author":"Rieck","year":"2013","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Shahidullah, M., Al-Malki, W.H., and Delamere, N.A. (2011). Mechanism of aqueous humor secretion, its regulation and relevance to glaucoma. Glaucoma Basic Clin. Concepts.","DOI":"10.5772\/26559"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1006\/exer.1994.1158","article-title":"Aqueous humor in glaucomatous eyes contains an increased level of TGF-beta 2","volume":"59","author":"Tripathi","year":"1994","journal-title":"Exp. Eye Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3341\/kjo.2006.20.3.162","article-title":"Transforming growth factor-beta levels in human aqueous humor of glaucomatous, diabetic and uveitic eyes","volume":"20","author":"Min","year":"2006","journal-title":"Korean J. Ophthalmol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3928\/15428877-20070101-01","article-title":"Ben Increased levels of transforming growth factor-betal and -beta2 in the aqueous humor of patients with neovascular glaucoma","volume":"38","author":"Yu","year":"2007","journal-title":"Ophthalmic Surg. Lasers Imaging Off. J. Int. Soc. Imaging Eye"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/IJG.0b013e318050ab4b","article-title":"Aqueous humor sCD44 concentration and visual field loss in primary open-angle glaucoma","volume":"16","author":"Nolan","year":"2007","journal-title":"J. Glaucoma"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/j.1442-9071.2010.02318.x","article-title":"Erythropoietin and soluble CD44 levels in patients with primary open-angle glaucoma","volume":"38","author":"Mokbel","year":"2010","journal-title":"Clin. Exp. Ophthalmol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"553","DOI":"10.2147\/OPTH.S19453","article-title":"Tumor necrosis factor-alpha (TNF-\u03b1) levels in aqueous humor of primary open angle glaucoma","volume":"5","author":"Balaiya","year":"2011","journal-title":"Clin. Ophthalmol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1167\/iovs.11-8434","article-title":"Multiplex cytokine analysis of aqueous humor in eyes with primary open-angle glaucoma, exfoliation glaucoma, and cataract","volume":"53","author":"Takai","year":"2012","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0182571","article-title":"Comparison of cytokine profiles in the aqueous humor of eyes with pseudoexfoliation syndrome and glaucoma","volume":"12","author":"Garweg","year":"2017","journal-title":"PLoS ONE"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s10792-019-01207-4","article-title":"Angiogenic and inflammatory biomarker levels in aqueous humor and vitreous of neovascular glaucoma and proliferative diabetic retinopathy","volume":"40","author":"Sun","year":"2020","journal-title":"Int. Ophthalmol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12886-019-1183-1","article-title":"Aqueous humor levels of TGF-\u03b22 and SFRP1 in different types of glaucoma","volume":"19","author":"Guo","year":"2019","journal-title":"BMC Ophthalmol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-021-81048-3","article-title":"Aqueous autotaxin and TGF-\u03b2s are promising diagnostic biomarkers for distinguishing open-angle glaucoma subtypes","volume":"11","author":"Igarashi","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/aos.13899","article-title":"Intraocular cytokine profile and autoimmune reactions in retinitis pigmentosa, age-related macular degeneration, glaucoma and cataract","volume":"97","author":"Fazil","year":"2019","journal-title":"Acta Ophthalmol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1080\/02713683.2020.1762226","article-title":"Aqueous inflammation and ischemia-related biomarkers in neovascular glaucoma with stable iris neovascularization","volume":"45","author":"Sun","year":"2020","journal-title":"Curr. Eye Res."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Ban, N., Siegfried, C.J., Lin, J.B., Shui, Y.B., Sein, J., Pita-Thomas, W., Sene, A., Santeford, A., Gordon, M., and Lamb, R. (2017). GDF15 is elevated in mice following retinal ganglion cell death and in glaucoma patients. JCI Insight, 2.","DOI":"10.1172\/jci.insight.91455"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1167\/tvst.9.10.16","article-title":"Increased aqueous humor gdf15 is associated with worse visual field loss in pseudoexfoliative glaucoma patients","volume":"9","author":"Lin","year":"2020","journal-title":"Transl. Vis. Sci. Technol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/00061198-199704000-00003","article-title":"Plasma and aqueous humor endothelin levels in primary open-angle glaucoma","volume":"6","author":"Tezel","year":"1997","journal-title":"J. Glaucoma"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1097\/IJG.0000000000000553","article-title":"Klotho and endothelin-1 in pseudoexfoliation syndrome and glaucoma","volume":"25","author":"Ahoor","year":"2016","journal-title":"J. Glaucoma"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1136\/bjo.82.7.830","article-title":"Brain natriuretic peptide: Identification of a second natriuretic peptide in human aqueous humour","volume":"82","author":"Salzmann","year":"1998","journal-title":"Br. J. Ophthalmol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1080\/02713683.2016.1180397","article-title":"Association of NT-proANP level in plasma and humor aqueous with primary open-angle glaucoma","volume":"42","author":"Baumane","year":"2017","journal-title":"Curr. Eye Res."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12886-017-0623-z","article-title":"Link between neurodegeneration and trabecular meshwork injury in glaucomatous patients","volume":"17","author":"Zhang","year":"2017","journal-title":"BMC Ophthalmol."},{"key":"ref_60","first-page":"e768","article-title":"Tear and aqueous humour cytokine profile in primary open-angle glaucoma","volume":"98","year":"2020","journal-title":"Acta Ophthalmol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1034\/j.1600-0420.2002.800214.x","article-title":"Biochemical markers of the L-arginine-nitric oxide pathway in the aqueous humour in glaucoma patients","volume":"80","author":"Kotikoski","year":"2002","journal-title":"Acta Ophthalmol. Scand."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1136\/bjo.2003.028357","article-title":"Nitric oxide proxies and ocular perfusion pressure in primary open angle glaucoma","volume":"88","author":"Galassi","year":"2004","journal-title":"Br. J. Ophthalmol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S0002-9394(03)00788-8","article-title":"Oxidative stress markers in aqueous humor of glaucoma patients","volume":"137","author":"Ferreira","year":"2004","journal-title":"Am. J. Ophthalmol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/sj.eye.6702751","article-title":"Protein carbonyl levels in the aqueous humour and serum of patients with pseudoexfoliation syndrome","volume":"22","author":"Duman","year":"2008","journal-title":"Eye"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1007\/s00417-008-0871-y","article-title":"Prooxidant-antioxidant balance, peroxide and catalase activity in the aqueous humour and serum of patients with exfoliation syndrome or exfoliative glaucoma","volume":"246","author":"Koliakos","year":"2008","journal-title":"Graefe\u2019s Arch. Clin. Exp. Ophthalmol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"295","DOI":"10.3109\/02713680903548970","article-title":"Oxidative stress markers in patients with primary open-angle glaucoma","volume":"35","author":"Ghanem","year":"2010","journal-title":"Curr. Eye Res."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.exer.2012.07.011","article-title":"Aqueous humor oxidative stress proteomic levels in primary open angle glaucoma","volume":"103","author":"Bagnis","year":"2012","journal-title":"Exp. Eye Res."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"823","DOI":"10.3109\/02713683.2011.556299","article-title":"Evaluation of oxidative stress markers in aqueous humor of primary open angle glaucoma and primary angle closure glaucoma patients","volume":"39","author":"Goyal","year":"2014","journal-title":"Curr. Eye Res."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"4078","DOI":"10.1167\/iovs.17-22242","article-title":"Oxidative stress\u2013related molecular biomarker candidates for glaucoma","volume":"58","author":"Hondur","year":"2017","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/01.ijg.0000145812.39224.0a","article-title":"Matrix metalloproteinases and their tissue inhibitors in aqueous humor of patients with primary open-angle glaucoma, exfoliation syndrome, and exfoliation glaucoma","volume":"14","author":"Tervahartiala","year":"2005","journal-title":"J. Glaucoma"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1038\/eye.1998.224","article-title":"Cellular and plasma fibronectin in the aqueous humour of primary open-angle glaucoma, exfoliative glaucoma and cataract patients","volume":"12","author":"Vesaluoma","year":"1998","journal-title":"Eye"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.exer.2004.12.016","article-title":"Concentration of hyaluronic acid in primary open-angle glaucoma aqueous humor","volume":"80","author":"Navajas","year":"2005","journal-title":"Exp. Eye Res."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"540","DOI":"10.3109\/02713683.2011.565541","article-title":"Connective tissue growth factor and tissue inhibitor of matrix metalloproteinase-2 in patients with exfoliative glaucoma","volume":"36","author":"Ghanem","year":"2011","journal-title":"Curr. Eye Res."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/00061198-199902000-00011","article-title":"The relationship between gelatinase A activity in aqueous humor and glaucoma","volume":"8","author":"Kee","year":"1999","journal-title":"J. Glaucoma"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"3660","DOI":"10.1167\/iovs.10-5209","article-title":"Connective tissue growth factor is increased in pseudoexfoliation glaucoma","volume":"52","author":"Browne","year":"2011","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"107837","DOI":"10.1016\/j.exer.2019.107837","article-title":"Evaluation of tear and aqueous humor level, and genetic variants of connective tissue growth factor as biomarkers for early detection of pseudoexfoliation syndrome\/glaucoma","volume":"189","year":"2019","journal-title":"Exp. Eye Res."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1080\/02713683.2018.1449222","article-title":"Matricellular proteins play a potential role in acute primary angle closure","volume":"43","author":"Wang","year":"2018","journal-title":"Curr. Eye Res."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1080\/02713683.2019.1608261","article-title":"Detection of proteins associated with extracellular matrix regulation in the aqueous humour of patients with primary glaucoma","volume":"44","author":"Nikhalashree","year":"2019","journal-title":"Curr. Eye Res."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1002\/cbin.11138","article-title":"Possible role of differentially expressing novel protein markers (ligatin and fibulin-7) in human aqueous humor and trabecular meshwork tissue in glaucoma progression","volume":"43","author":"Basu","year":"2019","journal-title":"Cell Biol. Int."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1080\/02713683.2019.1698055","article-title":"Evaluation of tear fluid and aqueous humor concentration of clusterin as biomarkers for early diagnosis of pseudoexfoliation syndrome and pseudoexfoliative glaucoma","volume":"45","year":"2020","journal-title":"Curr. Eye Res."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s00417-019-04574-x","article-title":"Increased expression of periostin and tenascin-C in eyes with neovascular glaucoma secondary to PDR","volume":"258","author":"Ishikawa","year":"2020","journal-title":"Graefe\u2019s Arch. Clin. Exp. Ophthalmol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/eye.2016.300","article-title":"Biomarkers for glaucoma: From the lab to the clinic","volume":"31","author":"Kunst","year":"2017","journal-title":"Eye"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1080\/02713680701375183","article-title":"Antibodies to \u03b1 B-crystallin, vimentin, and heat shock protein 70 in aqueous humor of patients with normal tension glaucoma and IgG antibody patterns against retinal antigen in aqueous humor","volume":"32","author":"Joachim","year":"2007","journal-title":"Curr. Eye Res."},{"key":"ref_84","first-page":"1573","article-title":"IgG antibody patterns in aqueous humor of patients with primary open angle glaucoma and pseudoexfoliation glaucoma","volume":"13","author":"Joachim","year":"2007","journal-title":"Mol. Vis."},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Nezu, N., Usui, Y., Saito, A., Shimizu, H., Asakage, M., Yamakawa, N., Tsubota, K., Wakabayashi, Y., Narimatsu, A., and Umazume, K. (2021). Machine learning approach for intraocular disease prediction based on aqueous humor immune mediator profiles. Ophthalmology.","DOI":"10.1016\/j.ophtha.2021.01.019"},{"key":"ref_86","first-page":"1437","article-title":"Transthyretin and complex protein pattern in aqueous humor of patients with primary open-angle glaucoma","volume":"14","author":"Grus","year":"2008","journal-title":"Mol. Vis."},{"key":"ref_87","first-page":"2839","article-title":"Proteomic analysis of aqueous humor from patients with primary open angle glaucoma","volume":"16","author":"Duan","year":"2010","journal-title":"Mol. Vis."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.exer.2010.11.004","article-title":"Identification of differentially expressed proteins in the aqueous humor of primary congenital glaucoma","volume":"92","author":"Bouhenni","year":"2011","journal-title":"Exp. Eye Res."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0165314","article-title":"Changes to the aqueous humor proteome during glaucoma","volume":"11","author":"Kaeslin","year":"2016","journal-title":"PLoS ONE"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1002\/pmic.201500423","article-title":"Human aqueous humor proteome in cataract, glaucoma, and pseudoexfoliation syndrome","volume":"16","author":"Kliuchnikova","year":"2016","journal-title":"Proteomics"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s10792-017-0791-0","article-title":"Comparative evaluation of the aqueous humor proteome of primary angle closure and primary open angle glaucomas and age-related cataract eyes","volume":"39","author":"Kaur","year":"2019","journal-title":"Int. Ophthalmol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1021\/acs.jproteome.8b00244","article-title":"Proteomic analysis of aqueous humor from primary open angle glaucoma patients on drug treatment revealed altered complement activation cascade","volume":"17","author":"Adav","year":"2018","journal-title":"J. Proteome Res."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1007\/s10792-018-0885-3","article-title":"Aqueous humor protein dysregulation in primary angle-closure glaucoma","volume":"39","author":"Adav","year":"2019","journal-title":"Int. Ophthalmol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1167\/iovs.17-23434","article-title":"Proteomic alterations in aqueous humor from patients with primary open angle glaucoma","volume":"59","author":"Sharma","year":"2018","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"108077","DOI":"10.1016\/j.exer.2020.108077","article-title":"The aqueous humor proteome of primary open angle glaucoma: An extensive review","volume":"197","author":"Hubens","year":"2020","journal-title":"Exp. Eye Res."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"4831","DOI":"10.1021\/pr1005372","article-title":"Proteome alterations in primary open angle glaucoma aqueous humor","volume":"9","author":"Izzotti","year":"2010","journal-title":"J. Proteome Res."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"4242","DOI":"10.1167\/iovs.11-8902","article-title":"New proteins as vascular biomarkers in primary open angle glaucomatous aqueous humor","volume":"53","author":"Centofanti","year":"2012","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"5353","DOI":"10.1167\/iovs.13-12245","article-title":"Elevated levels of multiple biomarkers of alzheimer\u2019s disease in the aqueous humor of eyes with open-angle glaucoma","volume":"54","author":"Inoue","year":"2013","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"5260","DOI":"10.1167\/iovs.10-6691","article-title":"During glaucoma, \u03b12-macroglobulin accumulates in aqueous humor and binds to nerve growth factor, neutralizing neuroprotection","volume":"52","author":"Bai","year":"2011","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1167\/iovs.13-12941","article-title":"Clusterin and complement activation in exfoliation glaucoma","volume":"55","author":"Doudevski","year":"2014","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"236","DOI":"10.5507\/bp.2020.028","article-title":"Metabolomic analysis in ophthalmology","volume":"164","author":"Radeva","year":"2020","journal-title":"Biomed. Pap."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ajo.2004.02.027","article-title":"Elevated homocysteine levels in aqueous humor of patients with pseudoexfoliation glaucoma","volume":"138","author":"Bleich","year":"2004","journal-title":"Am. J. Ophthalmol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.exer.2010.12.004","article-title":"Glaucoma patients present increased levels of diadenosine tetraphosphate, Ap4A, in the aqueous humour","volume":"92","author":"Castany","year":"2011","journal-title":"Exp. Eye Res."},{"key":"ref_104","first-page":"1841","article-title":"Increased malondialdehyde concentration and reduced total antioxidant capacity in aqueous humor and blood samples from patients with glaucoma","volume":"19","author":"Nucci","year":"2013","journal-title":"Mol. Vis."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1021\/acs.jproteome.8b00915","article-title":"Metabolomic profiling of aqueous humor in glaucoma points to taurine and spermine deficiency: Findings from the Eye-D study","volume":"18","author":"Buisset","year":"2019","journal-title":"J. Proteome Res."},{"key":"ref_106","first-page":"489","article-title":"Metabolomics of the aqueous humor in patients with primary congenital glaucoma","volume":"25","author":"Chen","year":"2019","journal-title":"Mol. Vis."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12886-020-01452-7","article-title":"Differential metabolic markers associated with primary open-angle glaucoma and cataract in human aqueous humor","volume":"20","author":"Pan","year":"2020","journal-title":"BMC Ophthalmol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"108268","DOI":"10.1016\/j.exer.2020.108268","article-title":"Metabolomic profiling of aqueous humor from glaucoma patients-the metabolomics in surgical ophthalmological patients (MISO) study","volume":"201","author":"Himmelreich","year":"2020","journal-title":"Exp. Eye Res."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"6523","DOI":"10.1167\/iovs.15-16793","article-title":"Angiogenic and inflammatory vitreous biomarkers associated with increasing levels of retinal ischemia","volume":"56","author":"Kovacs","year":"2015","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_110","first-page":"721","article-title":"Short communication: Increase of sialylated n-glycansin eyes with neovascular glaucoma secondary to proliferative diabetic retinopathy","volume":"41","author":"Inafuku","year":"2016","journal-title":"Curr. Eye Res."},{"key":"ref_111","first-page":"925","article-title":"Analyzing cytokines as biomarkers to evaluate severity of glaucoma","volume":"10","author":"Tong","year":"2017","journal-title":"Int. J. Ophthalmol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-12858-7","article-title":"Age-related neurodegenerative disease associated pathways identified in retinal and vitreous proteome from human glaucoma eyes","volume":"7","author":"Mirzaei","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1001\/archopht.1996.01100130295012","article-title":"Elevated glutamate levels in the vitreous body of humans and monkeys with glaucoma","volume":"114","author":"Dreyer","year":"1996","journal-title":"Arch. Ophthalmol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1038\/eye.2012.84","article-title":"Evaluation of corpus geniculatum laterale and vitreous fluid by magnetic resonance spectroscopy in patients with glaucoma; A preliminary study","volume":"26","author":"Doganay","year":"2012","journal-title":"Eye"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1001\/archopht.121.2.183","article-title":"Vitreous amino acid concentrations in patients with glaucoma undergoing vitrectomy","volume":"121","author":"Honkanen","year":"2003","journal-title":"Arch. Ophthalmol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1001\/archopht.118.5.666","article-title":"Matrix metalloproteinases and tumor necrosis factor alpha in glaucomatous optic nerve head","volume":"118","author":"Yan","year":"2000","journal-title":"Arch. Ophthalmol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/1098-1136(200010)32:1<42::AID-GLIA40>3.0.CO;2-3","article-title":"Tumor necrosis factor-alpha: A potentially neurodestructive cytokine produced by glia in the human glaucomatous optic nerve head","volume":"32","author":"Yuan","year":"2000","journal-title":"Glia"},{"key":"ref_118","first-page":"1787","article-title":"TNF-\u03b1 and TNF-\u03b1 receptor-1 in the retina of normal and glaucomatous eyes","volume":"42","author":"Tezel","year":"2001","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1001\/archopht.122.9.1348","article-title":"Hypoxia-inducible factor 1alpha in the glaucomatous retina and optic nerve head","volume":"122","author":"Tezel","year":"2004","journal-title":"Arch. Ophthalmol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1167\/iovs.05-1499","article-title":"Proteomics implicates peptidyl arginine deiminase 2 and optic nerve citrullination in glaucoma pathogenesis","volume":"47","author":"Bhattacharya","year":"2006","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.3109\/02713683.2011.611610","article-title":"A preliminary study of reduced expression of aquaporin-9 in the optic nerve of primate and human eyes with glaucoma","volume":"36","author":"Mizokami","year":"2011","journal-title":"Curr. Eye Res."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"8442","DOI":"10.1167\/iovs.11-8152","article-title":"Neurodegenerative and inflammatory pathway components linked to TNF-\u03b1\/TNFR1 signaling in the glaucomatous human retina","volume":"52","author":"Yang","year":"2011","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1167\/iovs.09-4014","article-title":"Hemoglobin expression and regulation in glaucoma: Insights into retinal ganglion cell oxygenation","volume":"51","author":"Tezel","year":"2010","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"5071","DOI":"10.1167\/iovs.10-5289","article-title":"Oxidative stress and the regulation of complement activation in human glaucoma","volume":"51","author":"Tezel","year":"2010","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep29759","article-title":"Glaucoma related proteomic alterations in human retina samples","volume":"6","author":"Funke","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"6080","DOI":"10.1074\/jbc.M411233200","article-title":"Proteomics reveal cochlin deposits associated with glaucomatous trabecular meshwork","volume":"280","author":"Bhattacharya","year":"2005","journal-title":"J. Biol. Chem."},{"key":"ref_127","first-page":"1028","article-title":"Upregulation of Copine1 in trabecular meshwork cells of POAG patients: A membrane proteomics approach","volume":"14","author":"Zhang","year":"2008","journal-title":"Mol. Vis."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1021\/bi701517m","article-title":"Isolevuglandin-modified proteins, including elevated levels of inactive calpain-1, accumulate in glaucomatous trabecular meshwork","volume":"47","author":"Govindarajan","year":"2008","journal-title":"Biochemistry"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/s12325-016-0285-x","article-title":"Differential protein expression profiles in glaucomatous trabecular meshwork: An evaluation study on a small primary open angle glaucoma population","volume":"33","author":"Micera","year":"2016","journal-title":"Adv. Ther."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13167-016-0065-3","article-title":"Tear fluid biomarkers in ocular and systemic disease: Potential use for predictive, preventive and personalised medicine","volume":"7","author":"Hagan","year":"2016","journal-title":"EPMA J."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"4225","DOI":"10.2174\/0929867325666181009153212","article-title":"Structural and molecular tear film changes in glaucoma","volume":"26","author":"Mastropasqua","year":"2019","journal-title":"Curr. Med. Chem."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1039\/C1MB05357D","article-title":"Differential protein expression in tears of patients with primary open angle and pseudoexfoliative glaucoma","volume":"8","author":"Pieragostino","year":"2012","journal-title":"Mol. Biosyst."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1136\/bjo.2006.101485","article-title":"Measurement of inflammatory cytokines by multicytokine assay in tears of patients with glaucoma topically treated with chronic drugs","volume":"91","author":"Malvitte","year":"2007","journal-title":"Br. J. Ophthalmol."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1016\/j.ophtha.2010.03.064","article-title":"Tear cytokine profile in medicated glaucoma patients: Effect of monocyte chemoattractant protein 1 on early posttrabeculectomy outcome","volume":"117","author":"Chong","year":"2010","journal-title":"Ophthalmology"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"7385","DOI":"10.1167\/iovs.10-6532","article-title":"Proteomic profiling of inflammatory signaling molecules in the tears of patients on chronic glaucoma medication","volume":"52","author":"Wong","year":"2011","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/2211-5463.12637","article-title":"Comparative analysis of cytokine profiles of glaucomatous tears and aqueous humour reveals potential biomarkers for trabeculectomy complications","volume":"9","author":"Traverso","year":"2019","journal-title":"FEBS Open Bio."},{"key":"ref_137","doi-asserted-by":"crossref","unstructured":"Sedlak, L., Wojnar, W., Zych, M., and Wygl\u0119dowska-Promie\u0144ska, D. (2020). Influence of timolol, benzalkonium-preserved timolol, and benzalkonium-preserved brimonidine on oxidative stress biomarkers in the tear film. Cutan. Ocul. Toxicol., 1\u20139.","DOI":"10.1080\/15569527.2020.1787435"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.jtos.2017.03.004","article-title":"Tear cytokine profile of glaucoma patients treated with preservative-free or preserved latanoprost","volume":"15","author":"Urcelay","year":"2017","journal-title":"Ocul. Surf."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.optm.2008.09.014","article-title":"Brain-derived neurotrophic factor in patients with normal-tension glaucoma","volume":"80","author":"Ghaffariyeh","year":"2009","journal-title":"Optometry"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1167\/iovs.17-21723","article-title":"Functional activity of matrix metalloproteinases 2 and 9 in tears of patients with glaucoma","volume":"58","author":"Sahay","year":"2017","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_141","first-page":"455","article-title":"Omics biomarkers in ophthalmology","volume":"58","author":"Ramirez","year":"2017","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0201740","article-title":"Tear biomarkers in latanoprost and bimatoprost treated eyes","volume":"13","author":"Reddy","year":"2018","journal-title":"PLoS ONE"},{"key":"ref_143","first-page":"799","article-title":"Ciliary neurotrophic factor in patients with primary open-angle glaucoma and age-related cataract","volume":"23","author":"Shpak","year":"2017","journal-title":"Mol. Vis."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1039\/c3mb25463a","article-title":"Shotgun proteomics reveals specific modulated protein patterns in tears of patients with primary open angle glaucoma na\u00efve to therapy","volume":"9","author":"Pieragostino","year":"2013","journal-title":"Mol. Biosyst."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"411","DOI":"10.2147\/OPTH.S125364","article-title":"Cytokine biomarkers in tear film for primary open-angle glaucoma","volume":"11","author":"Gupta","year":"2017","journal-title":"Clin. Ophthalmol."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"S129","DOI":"10.1097\/ICL.0000000000000663","article-title":"Biomarkers in Tears and Ocular Surface: A Window for Neurodegenerative Diseases","volume":"46","author":"Roda","year":"2020","journal-title":"Eye Contact Lens"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/IJG.0b013e31802d6942","article-title":"Homocysteine in tear fluid of patients with pseudoexfoliation glaucoma","volume":"16","author":"Roedl","year":"2007","journal-title":"J. Glaucoma"},{"key":"ref_148","doi-asserted-by":"crossref","unstructured":"Rossi, C., Cicalini, I., Cufaro, M.C., Agnifili, L., Mastropasqua, L., Lanuti, P., Marchisio, M., De Laurenzi, V., Del Boccio, P., and Pieragostino, D. (2019). Multi-omics approach for studying tears in treatment-na\u00efve glaucoma patients. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20164029"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/sj.eye.6701565","article-title":"Role of oxidative stress enzymes in open-angle glaucoma","volume":"19","author":"Yildirim","year":"2005","journal-title":"Eye"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1167\/iovs.04-0777","article-title":"Systemic reduction in glutathione levels occurs in patients with primary open-angle glaucoma","volume":"46","author":"Gherghel","year":"2005","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_151","first-page":"1260","article-title":"Variability of serum oxidative stress biomarkers relative to biochemical data and clinical parameters of glaucoma patients","volume":"16","author":"Engin","year":"2010","journal-title":"Mol. Vis."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.yexmp.2011.01.001","article-title":"Evaluation of oxidative stress markers in pathogenesis of primary open-angle glaucoma","volume":"90","author":"Majsterek","year":"2011","journal-title":"Exp. Mol. Pathol."},{"key":"ref_153","first-page":"231","article-title":"Effects of polymorphisms in vitamin E-, vitamin C-, and glutathione peroxidase-related genes on serum biomarkers and associations with glaucoma","volume":"19","author":"Sanz","year":"2013","journal-title":"Mol. Vis."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12886-017-0409-3","article-title":"Differences in serum oxidative status between glaucomatous and nonglaucomatous cataract patients","volume":"17","author":"Rokicki","year":"2017","journal-title":"BMC Ophthalmol."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"61","DOI":"10.4274\/tjo.galenos.2018.10734","article-title":"Role of oxidative stress in pseudoexfoliation syndrome and pseudoexfoliation glaucoma","volume":"49","author":"Yaz","year":"2019","journal-title":"Turkish J. Ophthalmol."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0049680","article-title":"Status of systemic oxidative stresses in patients with primary open-angle glaucoma and pseudoexfoliation syndrome","volume":"7","author":"Tanito","year":"2012","journal-title":"PLoS ONE"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1177\/1120672119839582","article-title":"Evaluation of dynamic thiol\u2013disulfide homeostasis in glaucoma patients and the correlation with retinal nerve fiber layer analysis","volume":"30","author":"Gulpamuk","year":"2020","journal-title":"Eur. J. Ophthalmol."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1080\/02713683.2019.1594925","article-title":"Thiol\u2013Disulfide homeostasis and serum ischemia modified albumin levels in patients with primary open\u2013angle glaucoma","volume":"44","author":"Karakurt","year":"2019","journal-title":"Curr. Eye Res."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1371\/journal.pone.0027218","article-title":"The evaluation of the oxidative stress parameters in patients with primary angle-closure glaucoma","volume":"6","author":"Chang","year":"2011","journal-title":"PLoS ONE"},{"key":"ref_160","doi-asserted-by":"crossref","unstructured":"Li, S., Shao, M., Li, Y., Li, X., Wan, Y., Sun, X., and Cao, W. (2020). Relationship between oxidative stress biomarkers and visual field progression in patients with primary angle closure glaucoma. Oxid. Med. Cell. Longev., 2020.","DOI":"10.1155\/2020\/2701539"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"959","DOI":"10.3109\/02713683.2013.794246","article-title":"Decreased total antioxidants in patients with primary open angle glaucoma","volume":"38","author":"Kondkar","year":"2013","journal-title":"Curr. Eye Res."},{"key":"ref_162","first-page":"41","article-title":"Oxidative DNA damage and total antioxidant status in glaucoma patients","volume":"17","author":"Sorkhabi","year":"2011","journal-title":"Mol. Vis."},{"key":"ref_163","doi-asserted-by":"crossref","unstructured":"Kondkar, A.A., Azad, T.A., Sultan, T., Osman, E.A., Almobarak, F.A., and Al-Obeidan, S.A. (2020). Elevated plasma level of 8-Hydroxy-2\u2032-deoxyguanosine is associated with primary open-angle glaucoma. J. Ophthalmol., 2020.","DOI":"10.1155\/2020\/6571413"},{"key":"ref_164","first-page":"1","article-title":"Oxidative and anti-oxidative stress markers in chronic glaucoma: A systematic review and meta-analysis","volume":"11","author":"Pereira","year":"2016","journal-title":"PLoS ONE"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0002-9394(99)80084-1","article-title":"Anti-Ro\/SS-A positivity and heat shock protein antibodies in patients with normal-pressure glaucoma","volume":"125","author":"Wax","year":"1998","journal-title":"Am. J. Ophthalmol."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0002-9394(00)00862-X","article-title":"T cell subsets and sIL-2R\/IL-2 levels in patients with glaucoma","volume":"131","author":"Yang","year":"2001","journal-title":"Am. J. Ophthalmol."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1167\/iovs.18-26129","article-title":"T-lymphocyte subset distribution and activity in patients with glaucoma","volume":"60","author":"Yang","year":"2019","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_168","first-page":"1657","article-title":"Retinal ganglion cells recognized by serum autoantibody against gamma-enolase found in glaucoma patients","volume":"41","author":"Maruyama","year":"2000","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"ref_169","first-page":"1273","article-title":"Serum autoantibody against glutathione S-transferase in patients with glaucoma","volume":"42","author":"Yang","year":"2001","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1046\/j.1365-2249.2001.01578.x","article-title":"Antiphosphatidylserine antibodies are elevated in normal tension glaucoma","volume":"125","author":"Kremmer","year":"2001","journal-title":"Clin. Exp. Immunol."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1001\/archopht.117.7.917","article-title":"Serum autoantibodies to optic nerve head glycosaminoglycans in patients with glaucoma","volume":"117","author":"Tezel","year":"1999","journal-title":"Arch. Ophthalmol."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1167\/iovs.05-0685","article-title":"Serum autoantibodies to \u03b1-fodrin are present in glaucoma patients from Germany and the United States","volume":"47","author":"Grus","year":"2006","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"8222","DOI":"10.1167\/iovs.12-10076","article-title":"Immunoproteomic analysis of potential serum biomarker candidates in human glaucoma","volume":"53","author":"Tezel","year":"2012","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.bbi.2011.07.241","article-title":"New insights into autoantibody profiles from immune privileged sites in the eye: A glaucoma study","volume":"26","author":"Boehm","year":"2012","journal-title":"Brain. Behav. Immun."},{"key":"ref_175","doi-asserted-by":"crossref","unstructured":"Beutgen, V.M., Perumal, N., Pfeiffer, N., and Grus, F.H. (2019). Autoantibody biomarker discovery in primary open angle glaucoma using serological proteome analysis (SERPA). Front. Immunol., 10.","DOI":"10.3389\/fimmu.2019.00381"},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/cti2.1101","article-title":"Autoantigens in the trabecular meshwork and glaucoma-specific alterations in the natural autoantibody repertoire","volume":"9","author":"Beutgen","year":"2020","journal-title":"Clin. Transl. Immunol."},{"key":"ref_177","doi-asserted-by":"crossref","unstructured":"Shin, Y.J., Kim, E., Han, B.K., and Yi, K. (2020). Serum biomarkers for the diagnosis of glaucoma. Diagnostics, 11.","DOI":"10.3390\/diagnostics11010020"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1007\/s00417-005-0143-z","article-title":"Plasma thymulin and nerve growth factor levels in patients with primary open angle glaucoma and elevated intraocular pressure","volume":"244","author":"Noureddin","year":"2006","journal-title":"Graefe\u2019s Arch. Clin. Exp. Ophthalmol."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1136\/bjo.86.11.1299","article-title":"Plasma vascular endothelial growth factor, soluble VEGF receptor FLT-1, and von Willebrand factor in glaucoma","volume":"86","author":"Lip","year":"2002","journal-title":"Br. J. Ophthalmol."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/eye.1999.18","article-title":"Red blood cell membrane integrity in primary open angle glaucoma: Vivo and in vitro studies","volume":"13","author":"Zabala","year":"1999","journal-title":"Eye"},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.exer.2009.07.008","article-title":"Red blood cell plasmalogens and docosahexaenoic acid are independently reduced in primary open-angle glaucoma","volume":"89","author":"Acar","year":"2009","journal-title":"Exp. Eye Res."},{"key":"ref_182","first-page":"527","article-title":"Endothelin-1 levels and biomarkers of oxidative stress in glaucoma patients","volume":"35","author":"Villalba","year":"2014","journal-title":"Int. Ophthalmol."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1136\/bjo.2004.046755","article-title":"Increased plasma endothelin-1 levels in patients with progressive open angle glaucoma","volume":"89","author":"Emre","year":"2005","journal-title":"Br. J. Ophthalmol."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/IJG.0b013e3181b4cac7","article-title":"Serum cytokine alteration is associated with optic neuropathy in human primary open angle glaucoma","volume":"19","author":"Huang","year":"2010","journal-title":"J. Glaucoma"},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"701","DOI":"10.2147\/OPTH.S162999","article-title":"Association of increased levels of plasma tumor necrosis factor alpha with primary open-angle glaucoma","volume":"12","author":"Kondkar","year":"2018","journal-title":"Clin. Ophthalmol."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"153","DOI":"10.2147\/OPTH.S155168","article-title":"Elevated levels of plasma tumor necrosis factor alpha in patients with pseudoexfoliation glaucoma","volume":"12","author":"Kondkar","year":"2018","journal-title":"Clin. Ophthalmol."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"e815","DOI":"10.1097\/IJG.0000000000000392","article-title":"Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as novel biomarkers of primary open-angle glaucoma","volume":"25","author":"Ozgonul","year":"2016","journal-title":"J. Glaucoma"},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"68984","DOI":"10.18632\/oncotarget.16571","article-title":"The diagnostic value of white blood cell, neutrophil, neutrophil-to-lymphocyte ratio, and lymphocyte-to-monocyte ratio in patients with primary angle closure glaucoma","volume":"8","author":"Li","year":"2017","journal-title":"Oncotarget"},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1080\/09273948.2018.1545913","article-title":"Monocyte\/HDL Ratio and lymphocyte\/monocyte ratio in patients with pseudoexfoliation syndrome","volume":"28","author":"Mirza","year":"2020","journal-title":"Ocul. Immunol. Inflamm."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1080\/09273948.2019.1677916","article-title":"Neutrophil-To-Lymphocyte ratio as a potential biomarker of neovascular glaucoma","volume":"29","author":"Zhang","year":"2021","journal-title":"Ocul. Immunol. Inflamm."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/OPX.0b013e3181fc329f","article-title":"Brain-derived neurotrophic factor as a biomarker in primary open-angle glaucoma","volume":"88","author":"Ghaffariyeh","year":"2011","journal-title":"Optom. Vis. Sci."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0168565","article-title":"Exploring serum levels of Brain Derived Neurotrophic Factor and Nerve Growth Factor across glaucoma stages","volume":"12","author":"Oddone","year":"2017","journal-title":"PLoS ONE"},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1272\/jnms.JNMS.2020_87-605","article-title":"Serum brain-derived neurotrophic factor in glaucoma patients in Japan: An observational study","volume":"87","author":"Igarashi","year":"2020","journal-title":"J. Nippon Med. Sch."},{"key":"ref_194","first-page":"99","article-title":"Plasmatic neuroglobin during the primitive open-angle glaucoma","volume":"77","author":"Abessolo","year":"2019","journal-title":"Ann. Biol. Clin."},{"key":"ref_195","doi-asserted-by":"crossref","unstructured":"Gonz\u00e1lez-Iglesias, H., \u00c1lvarez, L., Garc\u00eda, M., Escribano, J., Rodr\u00edguez-Calvo, P.P., Fern\u00e1ndez-Vega, L., and Coca-Prados, M. (2014). Comparative proteomic study in serum of patients with primary open-angle glaucoma and pseudoexfoliation glaucoma. J. Proteom., 98.","DOI":"10.1016\/j.jprot.2013.12.006"},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1167\/iovs.16-20675","article-title":"Association of plasma complement C3 levels with primary angle-closure glaucoma in older women","volume":"58","author":"Li","year":"2017","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1097\/00061198-200402000-00013","article-title":"Increased Expression of Matrix Metalloproteinases in Mononuclear Blood Cells of Normal-Tension Glaucoma Patients","volume":"13","author":"Golubnitschaja","year":"2004","journal-title":"J. Glaucoma"},{"key":"ref_198","first-page":"1","article-title":"Serum heparan sulfate and chondroitin sulfate concentrations in patients with newly diagnosed exfoliative glaucoma","volume":"2019","author":"Maric","year":"2019","journal-title":"PeerJ"},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1006\/exer.1996.0005","article-title":"Decreased 3\u03b1-hydroxysteroid dehydrogenase activity in peripheral blood lymphocytes from patients with primary open angle glaucoma","volume":"62","author":"Weinstein","year":"1996","journal-title":"Exp. Eye Res."},{"key":"ref_200","first-page":"431","article-title":"Increased plasma levels of 20S proteasome \u03b1-subunit in glaucoma patients: An observational pilot study","volume":"8","author":"Wunderlich","year":"2002","journal-title":"Mol. Vis."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3109\/08820538.2015.1068341","article-title":"Serum Lipid Levels in Pseudoexfoliation Syndrome","volume":"32","author":"Kurtul","year":"2017","journal-title":"Semin. Ophthalmol."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s00417-010-1487-6","article-title":"Levels of plasma homocysteine in pseudoexfoliation glaucoma","volume":"249","author":"Tranchina","year":"2011","journal-title":"Graefe\u2019s Arch. Clin. Exp. Ophthalmol."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1089\/jop.2020.0023","article-title":"Analysis of plasma hydrogen sulfide, homocysteine, and l-cysteine in open-angle glaucoma patients","volume":"36","author":"Lin","year":"2020","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1089\/jop.2011.0062","article-title":"Plasma citrate levels as a potential biomarker for glaucoma","volume":"27","author":"Fraenkl","year":"2011","journal-title":"J. Ocul. Pharmacol. Ther. Off. J. Assoc. Ocul. Pharmacol. Ther."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bmjpo-2017-000023","article-title":"Plasma citrate concentration: A possible biomarker for glaucoma in children","volume":"1","author":"Michalczuk","year":"2017","journal-title":"BMJ Paediatr. Open"},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"e356","DOI":"10.1111\/aos.13789","article-title":"Association of serum uric acid levels with primary open-angle glaucoma: A 5-year case\u2013control study","volume":"97","author":"Li","year":"2019","journal-title":"Acta Ophthalmol."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1167\/iovs.11-8420","article-title":"Elevation of serum asymmetrical and symmetrical dimethylarginine in patients with advanced glaucoma","volume":"53","author":"Javadiyan","year":"2012","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.plefa.2005.11.007","article-title":"Primary open-angle glaucoma patients have reduced levels of blood docosahexaenoic and eicosapentaenoic acids","volume":"74","author":"Ren","year":"2006","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"key":"ref_209","doi-asserted-by":"crossref","unstructured":"Rong, S., Li, Y., Guan, Y., Zhu, L., Zhou, Q., Gao, M., Pan, H., Zou, L., and Chang, D. (2017). Long-chain unsaturated fatty acids as possible important metabolites for primary angle-closure glaucoma based on targeted metabolomic analysis. Biomed. Chromatogr., 31.","DOI":"10.1002\/bmc.3963"},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-36952-6","article-title":"Comprehensive measurements of hydroxylinoleate and hydroxyarachidonate isomers in blood samples from primary open-angle glaucoma patients and controls","volume":"9","author":"Umeno","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"5020","DOI":"10.1167\/iovs.15-16702","article-title":"Metabolome-wide association study of primary open angle glaucoma","volume":"56","author":"Burgess","year":"2015","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"4355","DOI":"10.1167\/iovs.18-24938","article-title":"A Metabolomics Profiling of Glaucoma Points to Mitochondrial Dysfunction, Senescence, and Polyamines Deficiency","volume":"59","author":"Leruez","year":"2018","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/aos.14021","article-title":"Potential metabolic markers in glaucoma and their regulation in response to hypoxia","volume":"97","author":"Vohra","year":"2019","journal-title":"Acta Ophthalmol."},{"key":"ref_214","doi-asserted-by":"crossref","unstructured":"Nzoughet, J.K., Guehlouz, K., Leruez, S., Gohier, P., Bocca, C., Muller, J., Blanchet, O., Bonneau, D., Simard, G., and Milea, D. (2020). A data mining metabolomics exploration of glaucoma. Metabolites, 10.","DOI":"10.3390\/metabo10020049"},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.molonc.2014.03.006","article-title":"Mass spectrometry based biomarker discovery, verification, and validation-quality assurance and control of protein biomarker assays","volume":"8","author":"Parker","year":"2014","journal-title":"Mol. Oncol."},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1021\/pr800538n","article-title":"Mass spectrometry based targeted protein quantification: Methods and applications","volume":"8","author":"Pan","year":"2009","journal-title":"J. Proteome Res."},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"3797","DOI":"10.1021\/bi400110b","article-title":"Targeted quantitation of proteins by mass spectrometry","volume":"52","author":"Liebler","year":"2013","journal-title":"Biochemistry"},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"BIO88","DOI":"10.1167\/iovs.17-21809","article-title":"Omics biomarkers in ophthalmology","volume":"58","author":"Lauwen","year":"2017","journal-title":"Investig. Ophthalmol. Vis. Sci."}],"container-title":["Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-7737\/10\/8\/763\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:43:39Z","timestamp":1760165019000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-7737\/10\/8\/763"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,10]]},"references-count":218,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2021,8]]}},"alternative-id":["biology10080763"],"URL":"https:\/\/doi.org\/10.3390\/biology10080763","relation":{},"ISSN":["2079-7737"],"issn-type":[{"value":"2079-7737","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,10]]}}}